Report from Asian News International brought to you by HT Syndication.

London, March 24 -- A new study conducted by researchers at the University of Cambridge has provided a number of promising new drug targets for Huntington's disease, a neurodegenerative disease.

They have identified a number of candidate drugs to study further as to which encourage cells to eat the malformed proteins that causes the disease.

Huntington's disease is marked by build up of malformed proteins in brain cells, mainly in the basal ganglia and the cerebral cortex.

Generally, cells dispose of or recycle their waste material, including unwanted ...